Zymeworks
2 followers
‌
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.
Industries
Headquarters
Employees
Links
Org chart
Kenneth Galbraith
Chair & CEO
Kenneth Galbraith
Collapse
Chris Astle
SVP & CFO
Paul Moore
Chief Scientific Officer
Daniel Dex
SVP, Corporate Secretary & General Counsel
Mark Hollywood
SVP, Technical & Manufacturing Operations
Jeffrey Smith
EVP & Chief Medical Officer
John Fann
Senior Vice President, Technical Operation/process Sciences
Barbara Schaeffler
VP, Clinical Development Operations
Lucas Donigian
VP, Business & Commercial Development
Bijal Desai
VP, Finance & Strategy
Cathie Graham
VP, Legal
Laura O’Connor
VP, Human Resources & DEI
Lindsey Foulkes
VP, Corporate Development
Josemund Menezes
MD, Early-Stage Development, Asia Pacific
Franchesca Nguyen Mph
Director, Program And Alliance Management
Lin Yang
Associate Director Biostatistics
Jamie Rich
Senior Director, Technology | ADC Therapeutic Development
Thomas Spreter von Kreudenstein
Director, Protein Engineering
Kurt Stahl
Principal Scientist, Toxicology
Peter Repenning
Associate Scientist, Multispecific Antibody Therapeutics
Wingkie Wong
Senior Research Associate
Morgan Ura
Compliance & Internal Controls Manager
William Ferguson
Sr. Computer Systems Validation Manager
Kavie
HRIS Analyst
Ari Katsiavos
Associate Director, Payroll, HRIS & Benefits
Ashley Nguyen
Senior Human Resources Business Partner
Ipek Albas (Assoc CIPD)
HR Specialist
Similar companies
CRISPR Therapeutics
9 followers
Oxford Nanopore Technologies
5 followers
Coherus BioSciences
5 followers
Denali Therapeutics
5 followers
Novotech
4 followers
Zealand
4 followers
REGENXBIO
3 followers
Quanterix
3 followers
Seres Therapeutics
3 followers
Axsome Therapeutics
2 followers
Arcus Biosciences
2 followers
Discover companies